Publications by authors named "Michael D Lock"

Claim this Profile
F
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.
Kelly G Knupp, Ingrid E Scheffer, An-Sofie Schoonjans, Joseph Sullivan, Lieven Lagae, Michael D Lock

Epilepsy Behav· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome.
Ingrid E Scheffer, Rima Nabbout, Lieven Lagae, Orrin Devinsky, Stéphane Auvin, Michael D Lock

Epilepsia· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12-17 Years in the United States.
James M McCarty, David Cassie, Lisa Bedell, Michael D Lock, Sean Bennett

Am J Trop Med Hyg· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2-5 Years in the United States.
James M McCarty, David Cassie, Lisa Bedell, Michael D Lock, Sean Bennett

Am J Trop Med Hyg· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6-17 Years.
James M McCarty, Emma C Gierman, Lisa Bedell, Michael D Lock, Sean Bennett

Am J Trop Med Hyg· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial.
James M McCarty, Michael D Lock, Sean Bennett, Kristin M Hunt, Jakub K Simon

Vaccine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
Douglas J Haney, Michael D Lock, Marc Gurwith, Jakub K Simon, Glenn Ishioka

Vaccine· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45.
James M McCarty, Michael D Lock, Kristin M Hunt, Jakub K Simon, Marc Gurwith

Vaccine· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Naïve Population.
Douglas J Haney, Michael D Lock, Jakub K Simon, Jason Harris, Marc Gurwith

Clin Vaccine Immunol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a Phase 3 vaccine efficacy trial.
David V Jobes, Melissa Daoust, Vivian Nguyen, Allan Padua, Suzanne Michele, Michael D Lock

AIDS Res Hum Retroviruses· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis